The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Baker Bros. Investments Ii, L.p. since 2018.
The trader's CIK number is 1551132.
At the time of the last reporting, Baker Bros. Investments Ii, L.p. was the Director of Genomic Health Inc. (stock ticker symbol GHDX).
Also see all insider trading activities at Genomic Health Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | GHDX | 0 | $0 | 2,188,279 | $155,417,263 | 0 | $0 |
| 2018 | GHDX | 0 | $0 | 233,054 | $17,921,707 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-12 | GHDX | Sale | 11,204 | 65.32 | 731,890 |
| 2019-04-11 | GHDX | Sale | 202,281 | 67.01 | 13,555,658 |
| 2019-04-12 | GHDX | Sale | 287,465 | 65.88 | 18,936,756 |
| 2019-04-08 | GHDX | Sale | 22,648 | 67.90 | 1,537,731 |
| 2019-04-09 | GHDX | Sale | 21,063 | 67.77 | 1,427,502 |
| 2019-04-10 | GHDX | Sale | 124,542 | 68.70 | 8,556,159 |
| 2019-04-10 | GHDX | Sale | 13,146 | 69.12 | 908,690 |
| 2019-04-05 | GHDX | Sale | 77,648 | 68.67 | 5,332,243 |
| 2019-04-04 | GHDX | Sale | 81,053 | 66.64 | 5,401,371 |
| 2019-04-03 | GHDX | Sale | 97,269 | 68.90 | 6,701,736 |
| 2019-03-21 | GHDX | Sale | 56,651 | 74.71 | 4,232,169 |
| 2019-03-19 | GHDX | Sale | 50,100 | 74.34 | 3,724,584 |
| 2019-03-15 | GHDX | Sale | 55,347 | 75.25 | 4,164,806 |
| 2019-03-18 | GHDX | Sale | 109,533 | 74.19 | 8,125,924 |
| 2019-03-19 | GHDX | Sale | 105,126 | 74.63 | 7,845,658 |
| 2019-03-12 | GHDX | Sale | 74,180 | 75.63 | 5,610,233 |
| 2019-03-13 | GHDX | Sale | 80,253 | 75.79 | 6,082,294 |
| 2019-03-14 | GHDX | Sale | 65,094 | 76.27 | 4,964,459 |
| 2019-03-07 | GHDX | Sale | 2,000 | 73.72 | 147,444 |
| 2019-03-08 | GHDX | Sale | 22,700 | 73.55 | 1,669,516 |
| 2019-03-11 | GHDX | Sale | 49,035 | 74.56 | 3,655,902 |
| 2019-03-01 | GHDX | Sale | 79,276 | 77.39 | 6,135,486 |
| 2019-03-04 | GHDX | Sale | 27,811 | 76.49 | 2,127,263 |
| 2019-03-05 | GHDX | Sale | 10,300 | 77.04 | 793,501 |
| 2019-01-17 | GHDX | Sale | 181,747 | 70.79 | 12,866,051 |
| 2019-01-22 | GHDX | Sale | 12,800 | 71.61 | 916,646 |
| 2019-01-18 | GHDX | Sale | 177,142 | 72.51 | 12,844,212 |
| 2019-01-22 | GHDX | Sale | 51,606 | 71.00 | 3,664,026 |
| 2019-01-10 | GHDX | Sale | 10,185 | 70.28 | 715,781 |
| 2019-01-11 | GHDX | Sale | 28,474 | 70.22 | 1,999,529 |
| 2019-01-14 | GHDX | Sale | 600 | 70.07 | 42,043 |
| 2018-12-12 | GHDX | Sale | 18,500 | 73.09 | 1,352,091 |
| 2018-12-11 | GHDX | Sale | 57,554 | 73.35 | 4,221,528 |
| 2018-12-10 | GHDX | Sale | 9,366 | 73.83 | 691,482 |
| 2018-12-04 | GHDX | Sale | 32,776 | 76.12 | 2,495,073 |
| 2018-11-13 | GHDX | Sale | 114,858 | 79.76 | 9,161,533 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Investments Ii, L.p. (Director of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.